Xue Yuan, Wang Shipan, Zhang Xuehuan, Wang Xiaomeng, Shi Yue, Zhang Hongjia, Chen Duanduan, Li Haiyang
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Street, Beijing, 100029, Chaoyang District, China.
Lung and Blood Vessel Diseases, Beijing Institute of Heart, Beijing, 100029, China.
Cardiovasc Drugs Ther. 2024 Mar 15. doi: 10.1007/s10557-024-07565-1.
This study aims to investigate the clinical manifestations, operative techniques, and outcomes of patients who undergo open repair after thoracic endovascular aortic repair (TEVAR).
From January 2010 to June 2022, 113 consecutive type A aortic dissection (TAAD) patients underwent secondary open operation after TEVAR at our institution, and the median interval from primary intervention to open surgery was 12 (1.9-48.0) months. We divided the patients into two groups (RTAD (retrograde type A dissection) group, N = 56; PNAD (proximal new aortic dissection) group, N = 57) according to their anatomical features. Survival analysis during the follow-up was evaluated using a Kaplan-Meier survival curve and a log-rank test.
The 30-day mortality was 6.2% (7/113), the median follow-up period was 31.7 (IQR 14.7-65.6) months, and the overall survival at 1 year, 5 years, and 10 years was 88.5%, 88.5%, and 87.6%, respectively. Fourteen deaths occurred during the follow-up, but there were no late aorta-related deaths. Three patients underwent total thoracoabdominal aortic replacement 1 year after a second open operation. The RTAD group had a smaller ascending aorta size (42.5 ± 7.7 mm vs 48.4 ± 11.4 mm; P < .01) and a closer proximal landing zone (P < .01) compared to the PNAD group. However, there were no differences in survival between the two groups.
TAAD can present as an early or a late complication after TEVAR due to stent-grafting-related issues or disease progression. Open operation can be performed to treat TAAD, and this has acceptable early and mid-term outcomes. Follow-up should become mandatory for patients after TEVAR because these patients are at increased risk for TAAD.
本研究旨在探讨接受胸主动脉腔内修复术(TEVAR)后进行开放修复的患者的临床表现、手术技术及预后。
2010年1月至2022年6月,113例连续的A型主动脉夹层(TAAD)患者在我院接受了TEVAR术后的二期开放手术,从初次干预到开放手术的中位间隔时间为12(1.9 - 48.0)个月。根据解剖特征,我们将患者分为两组(逆行性A型夹层(RTAD)组,N = 56;近端新发主动脉夹层(PNAD)组,N = 57)。随访期间的生存分析采用Kaplan-Meier生存曲线和对数秩检验进行评估。
30天死亡率为6.2%(7/113),中位随访期为31.7(四分位间距14.7 - 65.6)个月,1年、5年和10年的总生存率分别为88.5%、88.5%和87.6%。随访期间发生14例死亡,但无晚期主动脉相关死亡。3例患者在二次开放手术后1年接受了全胸腹主动脉置换术。与PNAD组相比,RTAD组升主动脉直径较小(42.5±7.7mm对48.4±11.4mm;P <.01)且近端锚定区更近(P <.01)。然而,两组之间的生存率无差异。
由于支架移植物相关问题或疾病进展,TAAD可表现为TEVAR后的早期或晚期并发症。开放手术可用于治疗TAAD,且具有可接受的早期和中期预后。TEVAR术后的患者应进行强制性随访,因为这些患者发生TAAD的风险增加。